National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Adverse Drug Events (ADE) (1)
- (-) Adverse Events (4)
- (-) Blood Clots (4)
- Blood Pressure (1)
- Children/Adolescents (1)
- Chronic Conditions (1)
- Diabetes (1)
- Health Information Technology (HIT) (1)
- Medication (1)
- Medication: Safety (1)
- Patient Safety (2)
- Quality Improvement (1)
- Quality of Care (1)
- Risk (2)
- Surgery (3)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 4 of 4 Research Studies DisplayedShi J, Hurdle JF, Johnson SA
Natural language processing for the surveillance of postoperative venous thromboembolism.
The objective of the study was to develop a portal natural language processing approach to aid in the identification of postoperative venous thromboembolism events from free-text clinical notes. The investigators concluded that accurate surveillance of postoperative venous thromboembolism may be achieved using natural language processing on clinical notes in 2 independent health care systems. They indicated that these findings suggest natural language processing may augment manual chart abstraction for large registries such as National Surgical Quality Improvement Program.
AHRQ-funded; HS025776.
Citation: Shi J, Hurdle JF, Johnson SA .
Natural language processing for the surveillance of postoperative venous thromboembolism.
Surgery 2021 Oct;170(4):1175-82. doi: 10.1016/j.surg.2021.04.027..
Keywords: Blood Clots, Health Information Technology (HIT), Quality Improvement, Quality of Care, Surgery, Adverse Events
Khorfan R, Kreutzer L, Love R
Association between missed doses of chemoprophylaxis and VTE incidence in a statewide colectomy cohort.
The objectives of this study were to assess the incidence of missed doses of inpatient venous thromboembolism (VTE) chemoprophylaxis after colectomy in a statewide patient cohort and to examine the association between missed chemoprophylaxis doses and postoperative VTE. Findings showed that 13% of post-colectomy inpatients did not receive all prescribed doses of inpatient VTE chemoprophylaxis, and at least 1 missed dose of chemoprophylaxis was associated with an over twofold increased incidence of VTE among patients at high risk for VTE. Recommendations included verifying that patients receive all prescribed doses, identifying why doses are missed, and instituting quality improvement efforts to ensure patients receive all appropriate doses.
AHRQ-funded; HS024516.
Citation: Khorfan R, Kreutzer L, Love R .
Association between missed doses of chemoprophylaxis and VTE incidence in a statewide colectomy cohort.
Ann Surg 2021 Apr;273(4):e151-e52. doi: 10.1097/sla.0000000000004349..
Keywords: Blood Clots, Adverse Events, Surgery
Schlick CJR, Yuce TK, Yang AD
A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery.
Guidelines recommend extended chemoprophylaxis for venous thromboembolism in high-risk patients having operations for inflammatory bowel disease. Quantifying patients' risk of venous thromboembolism, however, remains challenging. In this study, the investigators sought (1) to identify factors associated with postdischarge venous thromboembolism in patients undergoing colorectal resection for inflammatory bowel disease and (2) to develop a postdischarge venous thromboembolism risk calculator to guide prescribing of extended chemoprophylaxis.
AHRQ-funded; HS024516; HS000078; HS026385.
Citation: Schlick CJR, Yuce TK, Yang AD .
A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery.
Surgery 2021 Feb;169(2):240-47. doi: 10.1016/j.surg.2020.09.006..
Keywords: Blood Clots, Adverse Events, Patient Safety, Surgery, Risk
Horton DB, Xie F, Chen L
Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous thromboembolism in children.
The purpose of this study was to quantify rates of incident treatment for diabetes mellitus, hypertension, and venous thromboembolism (VTE) associated with oral glucocorticoid exposure in children aged 1-18 years. Participants were identified using US Medicaid claims data and included more than 930,000 children diagnosed with autoimmune diseases or a nonimmune comparator condition. Findings showed strong dose-dependent relationships between current glucocorticoid exposure and all outcomes, suggesting strong relative risks, but low absolute risks, of newly-treated VTE, diabetes, and especially hypertension in children taking high-dose oral glucocorticoids.
AHRQ-funded; HS021110.
Citation: Horton DB, Xie F, Chen L .
Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous thromboembolism in children.
Am J Epidemiol 2021 Feb 1;190(3):403-12. doi: 10.1093/aje/kwaa197..
Keywords: Children/Adolescents, Diabetes, Chronic Conditions, Blood Clots, Medication: Safety, Medication, Adverse Drug Events (ADE), Adverse Events, Risk, Patient Safety, Blood Pressure